© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Grace Halsey
Articles
Menopausal VMS Severity, Frequency Reduced Significantly with Elinzanetant: Bayer Shares Data from Pivotal OASIS 1 and 2 Trials
May 17, 2024
The 2 phase 3 trials met all primary and secondary endpoints, showing statistically significant reduction in symptoms and sleep disturbance and improvement in quality of life.
Roche Says Investigational Once-Weekly "Twincretin" Shows Promise in Adults with Obesity in Early Stage Clinical Trial
May 17, 2024
In the phase 1b trial, treatment with once-weekly subcutaneous CT-388 led to a statistically significant mean placebo-adjusted weight loss of nearly 20%.
Lilly's Once-A-Week Insulin Demonstrates Safety, HbA1c Lowering Consistent with Daily Insulin
May 16, 2024
Safety and HbA1c reduction with efsitora alfa dosed once weekly was comparable to both daily insulin degludec and daily insulin glargine, announced Lilly.
Semaglutide Supports Long-Term Weight Loss, Reduces CV Risk Across BMI Subgroups
May 15, 2024
Analyses of the SELECT trial found mean weight loss of 10.2% sustained for 4 years and comparable CV benefit with weight loss greater or less than 5%, or even weight gain.
AstraZeneca at ATS 2024: Look for Late-Breaking Data on Novel Therapeutics for COPD
May 08, 2024
The company will present new data on effects of tezepelumab in COPD and of inhaled triple therapy Breztri on cardiopulmonary outcomes in COPD.
FDA Approves ColoSense, Novel Noninvasive Multitarget Stool RNA CRC Screening Test
May 07, 2024
In average-risk individuals, the at-home ColoSense test demonstrated 93% sensitivity for detecting CRC and 45% sensitivity for detecting advanced adenomas.
Preconception Vaping, Alcohol Use Had “No Meaningful Association” with Spontaneous Abortion in New Study
May 07, 2024
AUA 2024. Neither use of alcohol nor vaping/cigarette smoking by either parent during preconception was "appreciably" linked to an incident event, new research found.
CV Risk Prevention Profiles Significantly Worse Following Stroke vs MI in 2 Large National Cohorts
May 06, 2024
Study participants who had a history of stroke were nearly 60% less likely to meet guideline-recommended secondary prevention goals, new research reveals.
Can Colonoscopy Interval be Safely Extended from 10 to 15 Years for Individuals at Average CRC Risk?
May 03, 2024
New research suggests the interval "could potentially be extended" without significant harms and could reduce unnecessary invasive procedures. , ie, missed early detection and CRC-specific mortality.
Anxiety Linked to Increased Risk for Acute Exacerbations in Older Adults with COPD
May 02, 2024
Nearly 20% of an older cohort with COPD reported anxiety that was subsequently associated with more severe symptoms and acute exacerbations.